Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Tevogen Bio Inc
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
April 26, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
April 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
April 03, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
March 28, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Announces Series A-1 Preferred Stock Investment
March 27, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.